Assessment of Levels of Interferon Gamma (IFN-γ) and Interleukin-15 as Markers in Patients with Celiac Disease
DOI:
https://doi.org/10.46966/msjar.v5i3.197Keywords:
Celiac Disease, Interleukin-15, Interferon Gamma, Antibody.Abstract
Background: Celiac disease (CD) is a long-term digestive disorder caused by the immune system that affects people who are inherently more likely to get it. The ingestion of gluten-containing meals or beverages triggers the condition in those who are sensitive. The study aimed to serum levels of Tissue Transglutaminase (tTG-IgA and tTG-IgG), Interferon gamma (IFN-γ) and Iterleukin-15 in patients with celiac disease. Materials and methods: This case-control investigation was conducted at Marjan Hospital, Imam AL-Sadiq Hospital, and Al-Imam Ali Hospital. A convenience sampling of 146 samples. The study consisted of 73 patients with celiac disease (CD) and 73 healthy controls. 5 mL of venous blood was donated by each participant and subsequently deposited in gel containers (6 ml). The tubed blood is centrifuged at 3000 rpm for 10 minutes. The serum for Tissue Transglutaminase (tTG-IgA and tTG-IgG), Interferon gamma (IFN-γ) and Iterleukin-15 are stored in Eppendorf containers at -20 ºC until it is thawed on the day of the ELISA. Results: The present study found that patients had significantly higher levels of IL-15 (23.374±7.016) compared to controls (16.632±3.680), p-value < 0.001. In addition, the results report that Interferon gamma level was 11.268±5.381 in patients with celiac disease are higher significantly than the controls 7.461±2.304 with P. value <0.001. Conclusions: There was significant elevating in levels of Interferon gamma (IFN-γ) and Iterleukin-15 in patients with celiac disease. Furthermore, the study found that tTG IgA and IgG show a significant positive correlation. In addition, there was positive correlation between Interferon gamma with tTG (IgA and IgG), and IL-15.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jalal Sabr Eidan, and Assist. Prof. Dr. Hawraa Ameer Mubark
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
